Xenia Venture Capital is a hi-tech investment company publicly traded in the Tel Aviv Stock Exchange (TASE). Xenia is engaged in investing in early stage companies in the areas of high tech and med tech in Israel. Xenia also holds 50% of VLX, a technological incubator operating under the incubator program of the Office of the Chief Scientist of the State of Israel (OCS).
In addition to financing, Xenia provides its companies with top-notch mentoring, business and strategic counseling, fund raising assistance and exit planning, as well as basic infrastructure and peripheral services (finance & accounting, logistics, office support, etc).
Xenia management, board and advisory board are comprised of highly experienced entrepreneurs and business professionals with proven track records in various industries.
Since its inception in 2004, Xenia has invested in over 26 companies, which have attained significant technology and business achievements, resulting in substantial valuation increases.
Over the years, Xenia has obtained a significant position in the Israeli high tech eco system, and has established significant cooperation and strategic relations with leading partners in Israel, US, Europe and the Far East.
In 2007, Xenia Venture Capital formed a strategic alliance with VLSI, an investment fund formed by the Virginia Biosciences Commercialization Center which has resulted in close cooperation and co-investments in various portfolio companies in the med tech sector.